Cancer

In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.

In mice, a ketogenic diet remodeled the translatome of pancreatic cancer cells, rendering them vulnerable to targeted therapy.

Chemotherapy drugs can kill cancer cells by halting DNA replication, but a glucose-depleted environment can help cancer cells overcome this effect and resist death. 

A combination of three therapies prevented scar tissue and stopped glioblastoma in its tracks in mice.

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan.

Explore how a closed and integrated instrument workflow takes CAR T cell manufacturing to the next level.

A new algorithm detects when immunotherapies create surges of T cell responses in melanoma patients.

Discover how automation increases the efficiency and reliability of blood-based liquid biopsy assays.

New 3D blueprints that highlight tumor complexity reveal several new discoveries, some of which challenge existing theories of cancer progression.

Breast cancer cells send microRNA-filled vesicles to the brain, creating a nutrient-rich environment that facilitates metastasis. 

First-void urine has emerged as a promising sample type for cancer diagnostic test development.

Improved methods for circulating tumor cell capture and analysis can ensure reproducible biomarker and omics insights across different cancer types.

Fruit flies with gut tumors showed an increased preference for a bitter antitumor compound compared to healthy flies, suggesting a self-medication strategy. 

In this webinar, Christoph Herbel will discuss multiplexed spatial analyses that identify ovarian tumor antigens and CAR T cell candidates.

Proteins that trigger cell senescence occupy much of the literature on aging, but a small RNA moves into the limelight.

Learn how scientists address cancer cell therapy discovery and development difficulties.

When it comes to supplying their purine needs, cancer cells may use salvaged metabolites, according to a study in mice. 

Administering immunotherapy when the tumor microenvironment is most susceptible to T cells enhances treatment efficacy in mice.

Sequencing advances deliver comprehensive insights into how genomic variation drives cancer initiation and progression.